AUTOIMMUNITY
20.9K views | +14 today
AUTOIMMUNITY
Pathology, Diagnosis and Therapies
Your new post is loading...
Your new post is loading...
Suggested by Société Francaise d'Immunologie
March 7, 2015 3:52 PM
Scoop.it!

Cell-Intrinsic Expression of TLR9 in Autoreactive B Cells Constrains BCR/TLR7-Dependent Responses [AUTOIMMUNITY]

Endosomal TLRs play an important role in systemic autoimmune diseases, such as systemic erythematosus lupus, in which DNA- and RNA-associated autoantigens activate autoreactive B cells through TLR9- and TLR7-dependent pathways.
No comment yet.
Rescooped by Gilbert C FAURE from Autoimmune diseases (Lupus, RA), Vaccines and Stem Cell Therapies Highlights
February 24, 2015 2:24 PM
Scoop.it!

Sociodemographic and geographic predictors of quality of care in U.S. patients with end-stage renal disease due to lupus nephritis - Plantinga - Arthritis & Rheumatology - Wiley Online Library

Sociodemographic and geographic predictors of quality of care in U.S. patients with end-stage renal disease due to lupus nephritis - Plantinga - Arthritis & Rheumatology - Wiley Online Library | AUTOIMMUNITY | Scoop.it
Sociodemographic and geographic predictors of quality of care in US patients with end-stage lupus nephritis http://t.co/88kP2WttYr

 

Abstract

Objective. To describe end-stage renal disease (ESRD) quality of care (receipt of pre-ESRD nephrology care, access to kidney transplantation, and permanent vascular access placement for dialysis) in U.S. patients with ESRD due to lupus nephritis (LN-ESRD) and examine whether quality measures differed by patient sociodemographics or U.S. region.

Methods. In 6,594 U.S. patients initiating treatment for LN-ESRD (7/05-9/11), we estimated odds ratios (ORs) and hazard ratios (HRs) of each quality measure with sociodemographics and U.S. region using national surveillance data.

Results. Overall, 71% received nephrology care prior to ESRD. Blacks and Hispanics were less likely than whites to receive pre-ESRD care (OR=0.73, 95% CI 0.63-0.85 and OR=0.72, 95% CI 0.60-0.88) and to be placed on the kidney transplant waitlist (HR=0.78, 95% CI 0.68-0.81 and HR=0.82, 95% CI 0.68-0.98). Those with Medicaid (HR=0.51, 95% CI 0.44-0.58) or no insurance (HR=0.36, 95% CI 0.29-0.44) were less likely than those with private insurance to be placed on the waitlist. Only 24% had a permanent vascular access, and placement was even less likely among the uninsured (OR=0.62, 95% CI 0.49-0.79). ESRD quality-of-care measures varied 2- to 3-fold across regions, with patients in the Northeast and Northwest generally having higher probabilities of adequate care.


Via Krishan Maggon
Krishan Maggon 's curator insight, February 24, 2015 1:58 AM

Further studies are warranted to examine multi-level barriers to—and develop targeted interventions to improve delivery of—care among LN-ESRD patients. 


Sociodemographic and geographic predictors of quality of care in U.S. patients with end-stage renal disease due to lupus nephritisLaura C. Plantinga ScM1,2,*, Cristina Drenkard MD, PhD3, Rachel Patzer PhD5,6,Mitchel Klein PhD1, Michael R. Kramer PhD1, Stephen Pastan MD4,6, S. Sam Lim MD, MPH3 andWilliam M. McClellan MD, MPH1

DOI: 10.1002/art.38983

Copyright © 2014 American College of Rheumatology

Issue

Arthritis & Rheumatology

Accepted Article (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)


Suggested by Société Francaise d'Immunologie
February 9, 2015 2:04 PM
Scoop.it!

Expansion of an Atypical NK Cell Subset in Mouse Models of Systemic Lupus Erythematosus [AUTOIMMUNITY]

Chronic inflammatory conditions, such as in autoimmune disease, can disturb immune cell homeostasis and induce the expansion of normally rare cell populations.
No comment yet.
Scooped by Gilbert C FAURE
February 5, 2015 9:31 AM
Scoop.it!

Suppression of systemic autoimmunity by the innate immune adaptor S... - PubMed - NCBI

Proc Natl Acad Sci U S A. 2015 Feb 2. pii: 201420217. [Epub ahead of print]Full text in PNAS

Gilbert C FAURE's insight:

Cytosolic DNA-sensing pathways that signal via Stimulator of interferon genes (STING) mediate immunity to pathogens and also promote autoimmune pathology in DNaseII- and DNaseIII-deficient mice. In contrast, we report here that STING potently suppresses inflammation in a model of systemic lupus erythematosus (SLE)

No comment yet.
Scooped by Gilbert C FAURE
January 24, 2015 10:04 AM
Scoop.it!

Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy -- P...

Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy -- P... | AUTOIMMUNITY | Scoop.it
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephrit... http://t.co/78vzFQCDny
No comment yet.
Rescooped by Gilbert C FAURE from diabetes and more
January 12, 2015 9:17 AM
Scoop.it!

LJI researcher awarded $1.6 million grant to study factors that trigger onset of type 1 diabetes

The American Diabetes Association has awarded La Jolla Institute researcher Stephanie Stanford, Ph.D., a $1.6 million grant to investigate the genetic and environmental factors that trigger the onset of type 1 diabetes.

Via Ellen H Ullman, MSW
Gilbert C FAURE's insight:


PTPN22 http://www.ncbi.nlm.nih.gov/gene/26191

This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Mar 2009]

 

"We believe that when the PTPN22 gene is mutated, it impairs the body's immune response to viral infections, especially a specific enterovirus that is known to trigger type 1 diabetes by leaving the body vulnerable to an attack on the pancreas," Dr. Stanford said. "We also believe that certain environmental factors, including exposure to pathogens early in life, contribute to increased risk of type 1 diabetes."

No comment yet.
Scooped by Gilbert C FAURE
December 9, 2014 1:18 PM
Scoop.it!

Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE)

Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE) | AUTOIMMUNITY | Scoop.it
by Wei Jiang, Lumin Zhang, Ren Lang, Zihai Li, Gary Gilkeson
Introduction TLR7/8 and TLR9 signaling pathways have been extensively studied in systemic lupus erythematosus (SLE) as possible mediators of disease.
No comment yet.
Scooped by Gilbert C FAURE
November 24, 2014 2:05 PM
Scoop.it!

Anti-Ribosomal P Antibody Is a Key Autoantibody...

Anti-Ribosomal P Antibody Is a Key Autoantibody... | AUTOIMMUNITY | Scoop.it
Complications of neuropsychiatric systemic lupus erythematosus (NP-SLE) are associated with the morbidity and mortality of patients with SLE.
No comment yet.
Suggested by Société Francaise d'Immunologie
November 10, 2014 12:02 PM
Scoop.it!

Akt-Dependent Enhanced Migratory Capacity of Th17 Cells from Children with Lupus Nephritis [CLINICAL AND HUMAN IMMUNOLOGY]

Th17 cells infiltrate the kidneys of patients with lupus nephritis (LN) and are critical for the pathogenesis of this disease.
No comment yet.
Rescooped by Gilbert C FAURE from Autoimmune diseases (Lupus, RA), Vaccines and Stem Cell Therapies Highlights
October 28, 2014 12:13 PM
Scoop.it!

Preclinical Systemic Lupus Erythematosus

Preclinical Systemic Lupus Erythematosus | AUTOIMMUNITY | Scoop.it

Preclinical lupus encompasses a spectrum from enhanced SLE risk without clinical symptoms to individuals with autoantibodies and some SLE clinical features without meeting ACR classification. Studies have identified antibody and serological biomarkers years before disease onset. Incomplete lupus and undifferentiated connective tissue disease may occur during preclinical disease periods, but only 10–20% of these individuals transition to SLE and many have a mild disease course. Further studies are warranted to characterize biomarkers of early disease, identify individuals in need of close monitoring or preventive interventions, and elucidate mechanisms of disease pathogenesis without confounding factors of immunosuppressive medications or organ damage.


Via Krishan Maggon
Krishan Maggon 's curator insight, October 28, 2014 3:05 AM
Rheumatic Disease Clinics of North America

Volume 40, Issue 4, November 2014, Pages 621–635

Preclinical Rheumatic Disease

 Preclinical Systemic Lupus Erythematosus Julie M. Robertson, PhDa, Judith A. James, MD, PhDa, b, c, d, ,   DOI: 10.1016/j.rdc.2014.07.004
innovIDrsrchr's curator insight, November 3, 2014 9:17 AM

Bio markers have been elusive in SLE.

Scooped by Gilbert C FAURE
October 23, 2014 2:56 PM
Scoop.it!

Activation of rheumatoid factor-specific B cells is [J Immunol. 2014] - PubMed - NCBI

is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.

Gilbert C FAURE's insight:

Activated RF B cells preferentially differentiated into plasmablasts in EF zones. Contrary to the MRL/lpr strain, TC RF B cells were also located within germinal centers, but only the formation of EF foci was positively correlated with the production of RF AFCs. Immunization of young TC.AM14 H chain transgenic mice with IgG2a(a) anti-chromatin immune complexes (ICs) activated RF B cells in a BCR- and TLR9-dependent manner. However, these IC immunizations did not result in the production of RF AFCs. These results show that RF B cells break tolerance with the same general mechanisms in the TC and the MRL/lpr lupus-prone genetic backgrounds, namely the dual activation of the BCR and TLR9 pathways.

No comment yet.
Scooped by Gilbert C FAURE
October 10, 2014 5:11 AM
Scoop.it!

Self DNA from Lymphocytes That Have Undergone Activation-Induced Cell Death Enhances Murine B Cell Proliferation and Antibody Production

Self DNA from Lymphocytes That Have Undergone Activation-Induced Cell Death Enhances Murine B Cell Proliferation and Antibody Production | AUTOIMMUNITY | Scoop.it
by Qing Lu, Ji-Yang Wang, Luman Wang, Xuechao Jiang, Yiwei Chu
Systemic lupus erythematosus (SLE) is characterized by prominent autoinflammatory tissue damage associated with impaired removal of dying cells and DNA.
No comment yet.
Scooped by Gilbert C FAURE
October 6, 2014 1:29 PM
Scoop.it!

Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus

Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus [AUTOIMMUNITY] http://t.co/EztFkk6NOS #jimmTCB
No comment yet.
Scooped by Gilbert C FAURE
March 6, 2015 5:40 AM
Scoop.it!

UAB study to examine computer-based decision aids to help in lupus therapy - UAB News

UAB study to examine computer-based decision aids to help in lupus therapy - UAB News | AUTOIMMUNITY | Scoop.it
UAB is testing a tablet-based decision aid in hopes of improving outcomes for minority women with lupus and kidney disease Jasvinder SinghResearchers...
No comment yet.
Scooped by Gilbert C FAURE
February 19, 2015 1:43 PM
Scoop.it!

Lupus Research Institute announces this year's Novel Research Grants

Lupus Research Institute announces this year's Novel Research Grants | AUTOIMMUNITY | Scoop.it
As the Lupus Research Institute celebrates its 15th anniversary, the engine of innovation moves forward at accelerated speed with the announcement of this year's Novel Research Grants bringing new talent from a wide diversity of specialties.
No comment yet.
Suggested by Société Francaise d'Immunologie
February 7, 2015 6:43 AM
Scoop.it!

Efficacy and Cytokine Modulating Effects of Tacrolimus in Systemic Lupus Erythematosus: A Review

BioMed Research International (formerly titled Journal of Biomedicine and Biotechnology) is a peer-reviewed, open access journal that publishes original research articles as well as review articles in several areas of life sciences.
No comment yet.
Scooped by Gilbert C FAURE
January 25, 2015 1:59 PM
Scoop.it!

Evaluation of B lymphocyte stimulator and a pro...

Evaluation of B lymphocyte stimulator and a pro... | AUTOIMMUNITY | Scoop.it
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephrit... http://t.co/78vzFQCDny
No comment yet.
Scooped by Gilbert C FAURE
January 19, 2015 1:51 PM
Scoop.it!

Th17 cell counts higher in serum of patients with SLE vs. healthy controls - Healio

Th17 cell counts higher in serum of patients with SLE vs. healthy controls - Healio | AUTOIMMUNITY | Scoop.it
Rheumatology | Patients with systemic lupus erythematosus were shown to have higher levels of T helper 17 cells than healthy controls, according to study findings.A cohort of 48 women diagnosed with systemic lupus erythematosus (SLE) based on...
Gilbert C FAURE's insight:

 

not in serum, in blood

No comment yet.
Scooped by Gilbert C FAURE
December 11, 2014 11:51 AM
Scoop.it!

The multifaceted aspects of refractory lupus nephritis, Expert Review of Clinical Immunology, Informa Healthcare

The multifaceted aspects of refractory lupus nephritis, Expert Review of Clinical Immunology, Informa Healthcare | AUTOIMMUNITY | Scoop.it
The multifaceted aspects of refractory lupus nephritis: Expert Review of Clinical Immunology, Ahead of Print.
http://t.co/ZyskCRM20i
No comment yet.
Scooped by Gilbert C FAURE
December 1, 2014 12:52 PM
Scoop.it!

Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks - Rekvig - 2014 - Clinical & Experimental Immunology - Wiley Online Li...

Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks - Rekvig - 2014 - Clinical & Experimental Immunology - Wiley Online Li... | AUTOIMMUNITY | Scoop.it
AntidsDNA antibodies as aclassification criterion and a diagnostic marker for SEL Clinical & Experimental Immunology http://t.co/BhTBDH89sn
No comment yet.
Scooped by Gilbert C FAURE
November 20, 2014 2:42 PM
Scoop.it!

Anti-Ribosomal P Antibody Is a Key Autoantibody Associated with Complications of NP-SLE with High-Levels of CSF IL-8 - ACR Abstracts

Anti-Ribosomal P Antibody Is a Key Autoantibody Associated with Complications of NP-SLE with High-Levels of CSF IL-8 - ACR Abstracts | AUTOIMMUNITY | Scoop.it
Background/Purpose: Complications of neuropsychiatric systemic lupus erythematosus (NP-SLE) are associated with the morbidity and mortality of patients with SLE.
Gilbert C FAURE's curator insight, November 21, 2014 10:03 AM

among  searchable ACR abstracts 2012-2013-2014

 

 

Scooped by Gilbert C FAURE
November 1, 2014 2:35 PM
Scoop.it!

Invariant natural killer T cells in lupus patients promote IgG and ... - PubMed - NCBI

Eur J Immunol. 2014 Oct 29. doi: 10.1002/eji.201444760. [Epub ahead of print]
No comment yet.
Scooped by Gilbert C FAURE
October 23, 2014 3:19 PM
Scoop.it!

Belimumab after rituximab as maintenance therapy in lupus nephritis

Belimumab after rituximab as maintenance therapy in lupus nephritis | AUTOIMMUNITY | Scoop.it
RT @ElWheet: May be a reasonable strategy. "Belimumab after rituximab as maintenance therapy in lupus nephritis" http://t.co/i4Wtdfo0Wk
No comment yet.
Suggested by Société Francaise d'Immunologie
October 21, 2014 2:50 PM
Scoop.it!

B Cell-Intrinsic TLR7 Signaling Is Essential for the Development of Spontaneous Germinal Centers [AUTOIMMUNITY]

Spontaneous germinal center (Spt-GC) B cells and follicular helper T cells generate high-affinity autoantibodies that are involved in the development of systemic lupus erythematosus.
No comment yet.
Scooped by Gilbert C FAURE
October 8, 2014 5:12 AM
Scoop.it!

Meta-Analysis of Associations of IL1 Receptor Antagonist and Estrogen Receptor Gene Polymorphisms with Systemic Lupus Erythematosus Susceptibility

by Li Cai, Jin-wei Zhang, Xing-xin Xue, Zhi-gang Wang, Jia-jia Wang, Shai-di Tang, Shao-wen Tang, Jie Wang, Yun Zhang, Xian Xia
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects a number of different organs and tissues.
Krishan Maggon 's curator insight, October 8, 2014 6:19 AM

open access

 

PLoS One

 

OPEN ACCESS PEER-REVIEWEDRESEARCH ARTICLEMeta-Analysis of Associations of IL1 Receptor Antagonist and Estrogen Receptor Gene Polymorphisms with Systemic Lupus Erythematosus SusceptibilityLi Cai equal contributor,  Jin-wei Zhang equal contributor,  Xing-xin Xue,  Zhi-gang Wang,  Jia-jia Wang,  Shai-di Tang,  Shao-wen Tang,  Jie Wang,  Yun Zhang mail,  Xian Xia mail Published: October 06, 2014DOI: 10.1371/journal.pone.0109712